Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2007-10-01 Legal Proceedings Report
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Legal Proceedings Report 2007
Legal Proceedings Report Classification · 99% confidence The document is a press release dated September 28, 2007, announcing an update regarding the regulatory review process for Orexo's product, Rapinyl™, in Europe. It details that the product will be referred to the CHMP of the EMEA for review. This is not a full financial report (like 10-K or IR), nor is it a formal earnings release (ER) or a management discussion (MDA). It is an announcement concerning a specific business/regulatory event related to product development and licensing partnerships. Since it is a general business update that doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), the most appropriate general category for a significant, non-financial regulatory/business update that isn't a formal filing is Regulatory Filings (RNS), as it serves as a general regulatory/business announcement.
2007-10-01 English
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is a 'delårsrapport' (interim report) for Orexo AB covering the period January-June 2007. It contains detailed financial statements, including income statements, balance sheet data, and management commentary on business operations, product portfolios, and significant events. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2007
2007-08-14 Swedish
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report January - June 2007' for Orexo AB. It contains comprehensive financial statements (income statement in brief), analysis of business operations, key events, and product portfolio updates for the six-month period. It is a substantive financial report rather than an announcement or a certification, fitting the definition of an Interim/Quarterly Report. H1 2007
2007-08-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.